Dihexa Research for Cognitive Enhancement
An evidence-based overview of research examining Dihexa in the context of cognitive enhancement. This page synthesizes findings from peer-reviewed literature.
Research Summary
Dihexa was developed as a cognitive enhancer based on HGF/c-Met pathway modulation. Rodent studies showed reversal of scopolamine-induced memory deficits at extremely low doses. No human trials have been conducted, and all preclinical data comes from a single research group.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Cognitive Enhancement
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Dihexa has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.